Other news to note for Sept. 8, 2020 Sep. 8, 2020 Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: AB Science, Aegis Life, Albany Molecular Research, Amgen, Apogee, Arcturus, Astellas, Astrazeneca, Binex, City of Hope, Curevac, Decode Genetics, Elix, Elixirgen, Enesi, Entos, Harbour Biomed, HDT Bio, Körber, Medicinova, Nanoviricides, Neuclone, Oxford Biomedica, Parnell, Pharmabcine, Recce, Redhill, Relation, Twist, Walvax.Read More
Financings for Sept. 8, 2020 Sep. 8, 2020 Biopharmas in Asia-Pacific raising money in public or private financings, including: Aeon, Daewoong, Inxmed, Luca Science.Read More
Regulatory actions for Sept. 8, 2020 Sep. 8, 2020 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inspiremd, Roche, Theranica.Read More
Other news to note for Sept. 8, 2020 Sep. 8, 2020 Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus, Alkahest, Arches Research, Assure Holdings, Avacta, Cambus Medical, Co-Diagnostics, Confirm Biosciences, Cytosorbents, Diagnos, Diasorin, Fluidigm, Freudenberg Medical, Grifols, Inovio, Irhythm, Labcorp, Memed, Merit Medical, Neuronostics, Polarity TE, Qiagen, Roche Canada, Seegene, Thermo Fisher Scientific.Read More
In the clinic for Sept. 8, 2020 Sep. 8, 2020 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Helius Medical Technologies.Read More
Financings for Sept. 8, 2020 Sep. 8, 2020 Med-tech firms raising money in public or private financings, including: Enable Injections, Nanospectra Biosciences.Read More
Appointments and advancements for Sept. 8, 2020 Sep. 8, 2020 New hires and promotions in the med-tech industry, including: Assure Holdings, Bardy Diagnostics, Bruker, Davita, Dermtech, Medhub, Titan Medical.Read More
Regulatory actions for Sept. 8, 2020 Sep. 8, 2020 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aft, Arcutis, Aridis, Ascentage, Atara, Athena, Beyondspring, Caribou, Heron, Hyloris, Kadmon, Kleo, LNC, Marinomed, Ocular, Prometic, Protara, Roche, Silence, VBL.Read More
Other news to note for Sept. 8, 2020 Sep. 8, 2020 Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alkahest, Anges, Anheart, Aptorum, Astrazeneca, Auris, Aveo, Avidity, Biodesix, Biomica, Biontech, Briacell, Brickell, Canbridge, Catalent, Cheplapharm, CN, Cymerus, Daiichi Sankyo, Destiny, Exelixis, Exmceuticals, Glaxosmithkline, Grifols, Humanigen, Icanomab, Innovation, Inovio, Intravacc, Johnson & Johnson, Kite, Lineage Cell, Mab, Moderna, Mylan, NBE, Novavax, Pharmacyte, Pharmamar, Phoremost, Protalix, Recce, Redhill, Regenerx, Sanofi, Silence, Sporegen, Takeda, Vaxart, Vaxil, Vyne, Xtalpi, Zyversa.Read More
In the clinic for Sept. 8, 2020 Sep. 8, 2020 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Allena, Astrazeneca, Athenex, Bayer, Bellus, Biomarin, BMS, Calliditas, Celularity, Clene, Compugen, Corbus, Cyclo, Goldfinch, HRA Pharma, Insmed, Kamada, Merck, Novartis, Radius, Sanofi, Savara, Silence, Spero, Strongbridge, Synairgen, Transgene, Translate Bio, Valneva, Verona.Read More